Joaquin Duato
Chairman of the Board and Chief Executive Officer, Johnson & Johnson · since 2023-01-01
In the news
J&J Q3 2026 sales rise 5.9% to $25.4B; raises reported sales guidance
Johnson & Johnson reported third-quarter 2026 worldwide sales of $25.4 billion, up 5.9%, and adjusted EPS of $2.59, down 7.5%.
Earnings
J&J schedules Q3 2026 results and investor call for October 13
Johnson & Johnson announced that it will release third-quarter 2026 results around 6:45 a.m.
Earnings
Jennifer Taubert to retire; Tom Cavanaugh named head of Innovative Medicine
Johnson & Johnson said Executive Vice President Jennifer Taubert will retire after more than 21 years, and Tom Cavanaugh will succeed her as Executive Vice President and Worldwide Chairman of Innovative Medicine.
Management